Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NICERGOLINE Cause Basal cell carcinoma? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Basal cell carcinoma have been filed in association with NICERGOLINE. This represents 7.3% of all adverse event reports for NICERGOLINE.

5
Reports of Basal cell carcinoma with NICERGOLINE
7.3%
of all NICERGOLINE reports
0
Deaths
3
Hospitalizations

How Dangerous Is Basal cell carcinoma From NICERGOLINE?

Of the 5 reports, 3 (60.0%) required hospitalization, and 3 (60.0%) were considered life-threatening.

Is Basal cell carcinoma Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NICERGOLINE. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does NICERGOLINE Cause?

Somnolence (8) Abdominal pain (7) Agitation (7) Confusional state (7) Feeding disorder (7) Insomnia (7) Pruritus (7) Seizure (7) Erythema (6) Epilepsy (5)

What Other Drugs Cause Basal cell carcinoma?

ADALIMUMAB (1,547) INFLIXIMAB (1,340) METHOTREXATE (1,268) RITUXIMAB (1,085) ETANERCEPT (998) ABATACEPT (852) TOCILIZUMAB (761) LENALIDOMIDE (685) HYDROXYCHLOROQUINE (662) LEFLUNOMIDE (657)

Related Pages

NICERGOLINE Full Profile All Basal cell carcinoma Reports All Drugs Causing Basal cell carcinoma NICERGOLINE Demographics